Reconstruction and technical re-equipping of production of injectable drugs has been made at FSUE Moscow Endocrine Plant (hereinafter as the Enterprise), which is under jurisdiction of the Ministry of Industry and Trade of the Russian Federation as part of federal target program “Development of pharmaceutical and medical industry of the Russian Federation for the period up to 2020 and beyond”.
On January, 24, 2020, D.V. Manturov, the minister of Industry and Trade of the Russian Federation, S.S. Sobyanin, the mayor of Moscow and M. Yu. Fonarev, the General Director of FSUE Moscow Endocrine Plant Made symbolic start of production at FSUE Moscow Endocrine Plant (hereinafter as the Enterprise), which is under jurisdiction of the Ministry of Industry and Trade of the Russian Federation, the reconstruction and technical re-equipping of of injectable drugs has been made as part of federal target program “Development of pharmaceutical and medical industry of the Russian Federation for the period up to 2020 and beyond”.
On January, 24, 2020, D.V. Manturov, the minister of Industry and Trade of the Russian Federation, S.S. Sobyanin, the mayor of Moscow and M. Yu. Fonarev, the General Director of FSUE Moscow Endocrine Plant made symbolic start of production at the facility after reconstruction.
The opening ceremony was attended by S.A. Cyb - the First Deputy Minister of Industry and Trade of the Russian Federation, A.V. Alekhin - the Director of the Department for Development of Pharmaceutical and Medical Industry of the Ministry of Industry and Trade of the Russian Federation, V.V. Efimov - Deputy mayor of Moscow at the Moscow Government in the Matter of Economic Policy and Property and Land Relations, A.V. Rakova - Deputy mayor of Moscow at the Moscow Government in the Matter of Social Development, A.V. Prokhorov - Manager of the Department of Investment and Industrial Policy of Moscow, A.V. Cybin - Prefect of the South-Eastern administrative district of Moscow, P.A. Motyakin - Deputy Prefect of the South-Eastern administrative district of Moscow.
Reconstruction area totalled to 2 841 sq. m.
Total volume of investments into facility reconstruction made 1 222 100 129 rub., of which 906 946 395 rub. accounted for federal money, 315 153 734 rub. - Enterprise’s internal funds. “We managed to double the capacity of injection drugs production, up to 40 mln. Units per year, as well as to organise their production in new dosage forms - in pre-filled syringes with the capacity of 30 mln. units per year, and lyophilized products in glass vials, with the capacity of 6,5 mln. units per year” - said D.V. Manturov, the minister of Industry and Trade of the Russian Federation.
Reconstruction and technical re-equipping was performed in compliance with the international GMP standards, facilities are staffed with high-technology equipment from global producers, which increases the export potential of the Enterprise.
“The Enterprise is essential from the perspective of import substitution and realistic provision of our medicine, Moscow healthcare, drug stores with drug and psychotropic substances, provision of cancer sufferers with painkillers. Virtually, a great deal of the products are vital products that are necessary for people and that cannot be substituted”, emphasised S.S. Sobyanin, the mayor of Moscow. And at the facility, upon reconstruction.
The opening ceremony was attended by S.A. Cyb - the First Deputy Minister of Industry and Trade of the Russian Federation, A.V. Alekhin - the Director of the Department for Development of Pharmaceutical and Medical Industry of the Ministry of Industry and Trade of the Russian Federation, V.V. Efimov - Deputy mayor of Moscow at the Moscow Government in the Matter of Economic Policy and Property and Land Relations, A.V. Rakova - Deputy mayor of Moscow at the Moscow Government in the Matter of Social Development, A.V. Prokhorov - Manager of the Department of Investment and Industrial Policy of Moscow, A.V. Cybin - Prefect of the South-Eastern administrative district of Moscow, P.A. Motyakin - Deputy Prefect of the South-Eastern administrative district of Moscow. Reconstruction area totalled to 2 841 sq. m.
Total volume of investments into facility reconstruction made 1 222 100 129 rub., of which 906 946 395 rub. accounted for federal money, 315 153 734 rub. - Enterprise’s internal funds.
“We managed to double the capacity of injection drugs production, up to 40 mln. Units per year, as well as to organise their production in new dosage forms - in pre-filled syringes with the capacity of 30 mln. units per year, and lyophilized products in glass vials, with the capacity of 6,5 mln. units per year” - said D.V. Manturov, the minister of Industry and Trade of the Russian Federation.
Reconstruction and technical re-equipping was performed in compliance with the international GMP standards, facilities are staffed with high-technology equipment from global producers, which increases the export potential of the Enterprise.
“The Enterprise is essential from the perspective of import substitution and realistic provision of our medicine, Moscow healthcare, drug stores with drug and psychotropic substances, provision of cancer sufferers with painkillers. Virtually, a great deal of the products are vital products that are necessary for people and that cannot be substituted”, emphasised S.S. Sobyanin, the mayor of Moscow. the mayor of Moscow.
Comment type is not specified in the component properties.